Anti-IL-2Ra/CD25 Antibody (Daclizumab)
Catalog No.
F1272
Anti-IL-2Ra/CD25 Antibody (Daclizumab)
Featured Products
Daclizumab (Zenapax) is a humanized monoclonal antibody that blocks CD25, the alpha subunit of the high-affinity interleukin-2 receptor (IL-2R-HA). Daclizumab (Zenapax) reversibly binds to CD25 and blocks the interaction of IL-2 with IL-2R-HA. Daclizumab (Zenapax) can be used in multiple sclerosis research.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- COA (Certificate Of Analysis)
- MSDS (Material Safety Data Sheet)
- Datasheet
144.12 kDa
Dry ice
152923-56-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Zenapax, Zinbryta, dacliximab
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P01589
Human, Mouse, Rat, Rhesus
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human IL 2Rα His at 2 ug/mL can bind Anti-IL-2Ra/CD25 Antibody (Daclizumab)
IL-2Ra / CD25
Please avoid freeze-thaw cycles.